Kan jag skriva på det? Svar: Det beror på. Om inte en korrekt delegering finns på plats kan dessutom bara de som är chefer på bolaget skriva på kontrakt.

June 17, 2016

STAN-TONE MB-35904 ORANGE 9/17

September 17, 2014

Microsoft PowerPoint - Investor Day 2012_05072012.pptx Kurt S. Schuering Page 77 Appliance 5% Building & Construction 3% Wire & Cable Electrical & Electronics Consumer 21% Industrial 24% HealthCare 21% Transportation 17% 2011 Revenue: $1.0 Billion2011 Revenue: $1.0 Billion Key SuppliersKey Suppliers At a Glance Packaging 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% 2006 2007 2008 2009 2010 2011 2015 Operating Income % of Sales ROICROIC Expanding ProfitsExpanding Profits 15.3% 18.4% 22.4% 30.0% 39.2% 48.6% 2006 2007 2008 2009 2010 2011 Target 6 – 7.5% Page 78 Value Proposition and Transformation Highlights Value Proposition • North America-based distributor with expanding global reach providing key plastic processors and market segments with best-in-class suppliers products, service and delivery with a commitment to develop value-added solutions to enhance customer profitability Transformation Highlights • Significant market share gains with key suppliers , > $5B Addressable Market • Significant market share gains with key suppliers � Proprietary PolyOne technology � Dow Corning • Improved sales mix and profitability by shifting to non-cyclical businesses like healthcare • Established presence in Brazil and Asia in 2011 Page 79 Key Differentiators • Product offering � Breadth and depth; industry leading suppliers • Sales and marketing capability • Customer service / logistics operations � Customer survey results – consistent best-in-class performance � Leading on-time delivery • Management team experience and stability • Lean Six Sigma � Solving our customers’ unmet needs Page 80 $102.8 $207.2 Healthcare Revenue • Strong market segmentation provides focused resourcing to accelerate growth • Expanding global reach meets Areas of Focus $66.0 $182.4 National Accounts Revenue • Expanding global reach meets customers’ needs and creates competitive differentiation • Selling skills & product application knowledge to target executives & engineers ($ millions) Page 81 Critical Imperatives • Invest in commercial resources to accelerate growth • Expand healthcare and key account revenues • Broaden geographic reach and develop new markets and channel partnerships Critical Imperatives and 2015 Goal channel partnerships • Continue to improve working capital efficiency and superior cash flow generation 2015 Goal • 6 - 7.5% return on sales Page 82 Page 83

VI PROXY STATEMENT 2024 | Annual Meeting of Shareholders 17 Gregory J. Kunkle's 17-year tenure with the Company, Ms. 4) For purposes of this pay versus performance disclosure, our peer group is the S&P 400 Chemicals index (the "Peer Group").

Flow Length, inches (cm) Series Injection Velocity, 3 in/s (8 cm/s) Injection velocity, 5 in/s (13 cm/s) DynaflexTM D 13-15 (33-38) 18-20 (46-51) DynaflexTM G 12-22 (30-56) 18-30 (46-70) VersaflexTM 9-16 (23-41) 13-26 (33-66) VersalloyTM 18-20 (46-51) 30-32 (76-81) VersollanTM 12-17 (30-43) 19-22 (48-56) *Spiral flow tests performed using a 0.0625" (1.6mm) thick, 0.375" (9.5mm) wide channel at 400˚F (204˚C). Flow Length, inches (cm) Series Injection Velocity, 3 in/s (8 cm/s) Injection velocity, 5 in/s (13 cm/s) DynaflexTM D 13-15 (33-38) 18-20 (46-51) DynaflexTM G 12-22 (30-56) 18-30 (46-70) VersaflexTM 9-16 (23-41) 13-26 (33-66) VersalloyTM 18-20 (46-51) 30-32 (76-81) VersollanTM 12-17 (30-43) 19-22 (48-56) *Spiral flow tests performed using a 0.0625" (1.6mm) thick, 0.375" (9.5mm) wide channel at 400˚F (204˚C). TPE Injection Molding Injection Compression Extrusion Range V is co si ty , P a. s Shear Rate, 1/s 10,000 1,000 100 Figure 15 illustrates the range of viscosity of GLS overmolding TPEs.

A NR 989/2002 - ZMIENIONO §§ 4; 7 UST. 1, 2, 5; 9 UST. 2, 3, 4; 11 UST. 2, 5; 11A UST. 4; 12 UST. 2; 13 UST. 2; 17 UST. 2 UMOWY SPÓŁKI; 2 20.01.2010 R , REP. Strona 4 z 8 13 25.06.2014 OD 01.01.2013 DO 31.12.2013 14 13.07.2015 OD 01.01.2014 DO 31.12.2014 15 13.07.2016 OD 01.01.2015 DO 31.12.2015 16 12.06.2017 OD 01.01.2016 DO 31.12.2016 17 19.07.2018 OD 01.01.2017 DO 31.12.2017 18 31.10.2019 OD 01.01.2018 DO 31.12.2018 19 27.07.2020 OD 01.01.2019 DO 31.12.2019 2.Wzmianka o złożeniu opinii biegłego rewidenta / sprawozdania z badania rocznego sprawozdania finansowego 16 ***** OD 01.01.2017 DO 31.12.2017 17 ***** OD 01.01.2018 DO 31.12.2018 18 ***** OD 01.01.2019 DO 31.12.2019 3.Wzmianka o złożeniu uchwały lub postanowienia o zatwierdzeniu rocznego sprawozdania finansowego 16 ***** OD 01.01.2016 DO 31.12.2016 17 ***** OD 01.01.2017 DO 31.12.2017 Strona 5 z 8 18 ***** OD 01.01.2018 DO 31.12.2018 19 ***** OD 01.01.2019 DO 31.12.2019 4.Wzmianka o złożeniu sprawozdania z działalności podmiotu 16 ***** OD 01.01.2016 DO 31.12.2016 17 ***** OD 01.01.2017 DO 31.12.2017 18 ***** OD 01.01.2018 DO 31.12.2018 19 ***** OD 01.01.2019 DO 31.12.2019 Rubryka 3 ­ Sprawozdania grupy kapitałowej Rubryka 4 ­ Przedmiot działalności statutowej organizacji pożytku publicznego Rubryka 5 ­ Informacja o dniu kończącym rok obrotowy 1.Dzień kończący pierwszy rok obrotowy, za który należy złożyć sprawozdanie finansowe 31.12.2001 Dział 4 Rubryka 1 ­ Zaległości Rubryka 2 ­ Wierzytelności Rubryka 3 ­ Informacje o oddaleniu wniosku o ogłoszenie upadłości na podstawie art. 13 ustawy z 28 lutego 2003 r.

Home // Bringing Global Vision 2020’s USee™ to Life

Home // Bringing Global Vision 2020’s USee™ to Life